The University of Chicago Header Logo

Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host.

Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis. 1984 Jan; 149(1):1-8.

View in: PubMed